Concepedia

Abir Alatrach

AA

Statistics

Publications

3

Citations

255

H-Index

3

Active since

2013

Affiliations

Clinical Research Services(Current)

Bayer (Germany)

Abir Alatrach is an author at Clinical Research Services specializing in pharmacology, pharmacokinetics, and pharmacokinetics in liver dysfunction.

Publications per year

2013–2019

3

Publications

3

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct <scp>F</scp>actor <scp>X</scp>a inhibitor

Dagmar Kubitza, Angelika Roth, Michael Becka et al. · British Journal of Clinical Pharmacology · 2013 · 202 citations · Full text

, , +17

Interaction potential of the dual orexin receptor antagonist ACT-541468 with CYP3A4 and food: results from two interaction studies

Marie‐Laure Boof, Abir Alatrach, Mike Ufer et al. · European Journal of Clinical Pharmacology · 2018 · 28 citations

, , +12

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment

Roland Heinig, Marc Lambelet, Johannes Nagelschmitz et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2019 · 25 citations

, , +13

1–3 of 3